Li Kang Biomedical Co., Ltd. (6242.TWO)
TWD 43.9
(2.21%)
TWD 43.9
(2.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 629.37 Million | 684.25 Million | 386.96 Million | 456.72 Million | - |
| Cost of Revenue | 203.23 Million | 295.67 Million | 122.28 Million | 156.08 Million | - |
| Gross Profit | 426.14 Million | 388.57 Million | 264.68 Million | 300.63 Million | - |
| Operating Expenses | 292.77 Million | 251.21 Million | 207.43 Million | 219.69 Million | - |
| Selling, General and Administrative Expenses | 292.77 Million | 251.21 Million | 207.43 Million | 219.7 Million | - |
| Research and Development Expenses | - | - | - | - | 3000.00 |
| Other Expenses | - | 2.18 Million | 5.48 Million | 5.36 Million | - |
| Cost and Expenses | 496 Million | 546.89 Million | 329.72 Million | 375.78 Million | - |
| Operating Income | 133.37 Million | 141.08 Million | 63.93 Million | 87.49 Million | - |
| Interest Expense | 618 Thousand | 290 Thousand | 455 Thousand | 546 Thousand | 779 Thousand |
| Income Tax Expense | 28.15 Million | 28.7 Million | 12.04 Million | 17.67 Million | - |
| Earnings before Tax | 139.14 Million | 140.79 Million | 63.48 Million | 86.94 Million | - |
| Net Income | 110.99 Million | 112.09 Million | 51.43 Million | 69.26 Million | - |
| Earnings Per Share Basic | 4.14 | 4.18 | 1.86 | 2.50 | - |
| Earnings Per Share Diluted | 4.12 | 4.16 | 1.85 | 2.48 | - |
| Weighted Average Shares Outstanding | 26.8 Million | 27.72 Million | 27.72 Million | 27.72 Million | 27.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.95 Million | 27.88 Million | 27.85 Million | 27.91 Million | 27.91 Million |
| Gross Margin | 0.68 | 0.57 | 0.68 | 0.66 | - |
| EBIT Margin | 0.23 | 0.22 | 0.20 | 0.22 | - |
| Profit Margin | 0.18 | 0.16 | 0.13 | 0.15 | - |
| EBITDA | 145.11 Million | 152.07 Million | 76.82 Million | 102.5 Million | 106.07 Million |
| Earnings Before Tax Margin | 0.21 | 0.21 | 0.17 | 0.19 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 127.3 Million | 151.05 Million | 123.25 Million | 629.37 Million | 171.74 Million | 126.34 Million |
| Cost of Revenue | 40.8 Million | 47.02 Million | 38.87 Million | 203.23 Million | 53.9 Million | 39.52 Million |
| Gross Profit | 86.49 Million | 104.02 Million | 84.38 Million | 426.14 Million | 117.84 Million | 86.82 Million |
| Operating Expenses | 67.5 Million | 78.35 Million | 70.23 Million | 292.77 Million | 80.69 Million | 64.03 Million |
| Selling, General and Administrative Expenses | - | 78.35 Million | 70.23 Million | - | 80.69 Million | 64.03 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -67.5 Million | 799 Thousand | 1.3 Million | 3.12 Million | 1.06 Million | 242 Thousand |
| Cost and Expenses | 108.31 Million | 125.38 Million | 109.1 Million | 496 Million | 134.59 Million | 103.56 Million |
| Operating Income | 18.99 Million | 28.65 Million | 16.13 Million | 139.76 Million | 39.24 Million | 23.71 Million |
| Interest Expense | - | 263 Thousand | 314 Thousand | 618 Thousand | 371 Thousand | 247 Thousand |
| Income Tax Expense | 4.53 Million | 6.99 Million | 3.31 Million | 28.15 Million | 7.87 Million | 4.42 Million |
| Earnings before Tax | 21.62 Million | 28.39 Million | 15.82 Million | 139.14 Million | 38.87 Million | 23.46 Million |
| Net Income | 17.08 Million | 21.39 Million | 12.5 Million | 110.99 Million | 31 Million | 19.04 Million |
| Earnings Per Share Basic | 0.54 | 0.67 | 0.44 | - | 1.12 | 0.69 |
| Earnings Per Share Diluted | 0.54 | 0.67 | 0.43 | - | 1.12 | 0.69 |
| Weighted Average Shares Outstanding | 31.65 Million | 31.93 Million | 28.73 Million | 27.72 Million | 27.73 Million | 27.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.65 Million | 31.93 Million | 28.83 Million | 27.88 Million | 27.81 Million | 27.74 Million |
| Gross Margin | 0.68 | 0.69 | 0.68 | 0.68 | 0.69 | 0.69 |
| EBIT Margin | 0.15 | 0.21 | 0.16 | - | 0.25 | 0.21 |
| Profit Margin | 0.13 | 0.14 | 0.10 | 0.18 | 0.18 | 0.15 |
| EBITDA | 18.99 Million | 32 Million | 19.67 Million | - | 42.69 Million | 26.77 Million |
| Earnings Before Tax Margin | 0.15 | 0.19 | 0.13 | 0.22 | 0.23 | 0.19 |
MTA
DZSI
FLO
ZBH
LPDNF
SANA